Is it time to invest in marijuana stocks or should we wait for more favorable legislation? In this video I give my opinion and research on things I worry about …
3 responses to “Marijuana Industry, is it time to invest? Is there money to be made in weed stocks?”
If I was to buy any cannabis stock it would be VFF as of now only thing I own in that sector is GRWG which I been doing really good on them
Great video again. Holding SNDL. Sold half at 2x, holding the other half long term. They’re sitting on cash and will likely acquire more land or smaller competitors
👉🏻 ATNF (180 Life Sciences) Under the radar gem is an understatement. Potentially and very likely will trade 50X or more current stock price in due time. Co-Founded by Prof. Raphael Mechoulam "THE GODFATHER Of Cannabis Research" Discovered the Endocannabinoid system and isolating the two primary compounds, CBD and THC. ATNF has about a Tiny 1 million share true float with an addressable $150 Billion worldwide pipelines to address unmet needs of the number #1 cause of all autoimmune diseases in the world (Inflammation) and Chronic Pain Therapies with the Best Minds in the world. Dream Team All Star Management created drugs and companies that sold for over $100 BILLION. They are in Phase 3 the last phase of a potential $7.5 Billion (UK and US) and probably $20+ Billion worldwide therapy for Early Dupuytren’s Disease which there is NO other treatment available(NO competition). Phase 2 exceeded all primary endpoints. They are fully funded with grants (only the best of the best 1% ers receives grants) and cash on hand for 3 years (NO Dilution) as per CEO in their latest presentation on January 11th 2021. Market cap is tiny around $100 million. The patent portfolio covers 16 patent families with 42 patents issues and 32 pending in several important jurisdictions including the US, Canada, Europe, Australia, Japan and China. The 74 Incredible Patent portfolio alone is worth 8X the current stock price with more patents to be added as they are processed. Management owns 50% of the outstanding shares and 72% of outstanding shares cannot be sold for 12 Months and Management are NOT taking salaries.
👉🏻PT: $175.00 – $225.00 if gets FDA approval for Early Dupuytren’s therapy. Results of phase 3 coming in few months 👉🏻Add $150.00 on to Dupuytren’s therapy PT for any subsequent FDA approvals 👉🏻PT: $900.00++ If successful on the CBD pipeline therapies to disrupt and replace the addictive and deadly opioid market.
If I was to buy any cannabis stock it would be VFF as of now only thing I own in that sector is GRWG which I been doing really good on them
Great video again. Holding SNDL. Sold half at 2x, holding the other half long term. They’re sitting on cash and will likely acquire more land or smaller competitors
👉🏻 ATNF (180 Life Sciences) Under the radar gem is an understatement. Potentially and very likely will trade 50X or more current stock price in due time. Co-Founded by Prof. Raphael Mechoulam "THE GODFATHER Of Cannabis Research" Discovered the Endocannabinoid system and isolating the two primary compounds, CBD and THC. ATNF has about a Tiny 1 million share true float with an addressable $150 Billion worldwide pipelines to address unmet needs of the number #1 cause of all autoimmune diseases in the world (Inflammation) and Chronic Pain Therapies with the Best Minds in the world. Dream Team All Star Management created drugs and companies that sold for over $100 BILLION. They are in Phase 3 the last phase of a potential $7.5 Billion (UK and US) and probably $20+ Billion worldwide therapy for Early Dupuytren’s Disease which there is NO other treatment available(NO competition). Phase 2 exceeded all primary endpoints. They are fully funded with grants (only the best of the best 1% ers receives grants) and cash on hand for 3 years (NO Dilution) as per CEO in their latest presentation on January 11th 2021. Market cap is tiny around $100 million. The patent portfolio covers 16 patent families with 42 patents issues and 32 pending in several important jurisdictions including the US, Canada, Europe, Australia, Japan and China. The 74 Incredible Patent portfolio alone is worth 8X the current stock price with more patents to be added as they are processed. Management owns 50% of the outstanding shares and 72% of outstanding shares cannot be sold for 12 Months and Management are NOT taking salaries.
👉🏻PT: $175.00 – $225.00 if gets FDA approval for Early Dupuytren’s therapy. Results of phase 3 coming in few months
👉🏻Add $150.00 on to Dupuytren’s therapy PT for any subsequent FDA approvals
👉🏻PT: $900.00++ If successful on the CBD pipeline therapies to disrupt and replace the addictive and deadly opioid market.